-
Cowan Hobbs posted an update 2 days ago
The COVID-19 pandemic has limited the freedom of any citizen, further increased constraint for people in EHPAD – the most widespread type of French Residential care for senior citizens with a high level of dependency, often very aged, suffering multiple pathologies and sometimes psycho-behavioral disorders. “Golden” containment rule was 24/7…[Read more]
-
Cowan Hobbs posted an update 3 days ago
Novel approaches are needed for effective delivery of exercise in this population. Further studies are warranted for assessment of long-term benefits of exercise in pediatric CHD patients.
Exercise interventions are generally safe, feasible, and beneficial in children and adolescents with CHD. There is growing evidence demonstrating the…[Read more]
-
Cowan Hobbs posted an update 4 days ago
trials.gov/ct2/show/NCT03511131.
DERR1-10.2196/19701.
DERR1-10.2196/19701.
Advances in mobile health (mHealth) technology have made it possible for patients and health care providers to monitor and track behavioral health symptoms in real time. Ideally, mHealth apps include both passive and interactive monitoring and demonstrate…[Read more]
-
Cowan Hobbs posted an update 6 days ago
On the contrary, blink data suggested a difference in attention allocation, whereas self-report data indicated no difference in presence experiences. This demonstrates that beyond self-report and the analysis of event frequencies, the analysis of behavior structure offers insights into behavior synchronization between participants, allowing for…[Read more]
-
Cowan Hobbs posted an update 7 days ago
We introduced a humanoid robot for the use of techno-psychological distraction techniques in children aged 4-10 to reduce their anxiety and improve their behaviour during dental treatment.
Two hundred children (98 boys, 102 girls; mean age 6.5 ± 1.66 years) appointed for first time for dental caries were included and randomly divide…[Read more]
-
Cowan Hobbs posted an update 10 days ago
The results of bioinformatics analysis were further successfully validated in the clinical ESCA cohort by qRT-PCR and immunohistochemistry staining.
Our study constructed and validated an m6A RNA methylation regulators-based prognostic signature. This might provide important information for developing diagnostic and therapeutic…[Read more]
-